Upgrade to SI Premium - Free Trial

Ligand Pharma (LGND) PT Raised to $335 at Benchmark as XOMA Royalty Cash Acquisition Completed

July 16, 2026 7:57 AM
(Updated - July 16, 2026 9:56 AM EDT)

Benchmark analyst Robert Wasserman raised the price target on Ligand Pharma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change